Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Daniela Campanella |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder / Domenico De Berardis en Journal of Clinical Psychopharmacology, Año 2003 - Vol. 23 - No. 5 (Octubre)
[artículo]
Título : Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder Tipo de documento: texto impreso Autores: Domenico De Berardis, Autor ; Daniela Campanella, Autor ; Vincenzo Matera, Autor Fecha de publicación: 2023 Artículo en la página: pp. 451-458 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno bipolar, Distribución normal, Trombocitopenia. Resumen: To evaluate whether valproic acid (VPA) can cause thrombocytopenia and impaired platelet function in young patients with new-onset bipolar disorder.
The authors studied 25 new-onset young bipolar patients. Platelet count, platelet aggregation, platelet release, and bleeding time were evaluated before beginning VPA treatment and at least after 10 months of treatment.Link: ./index.php?lvl=notice_display&id=30998
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 5 (Octubre) . - pp. 451-458[artículo] Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder [texto impreso] / Domenico De Berardis, Autor ; Daniela Campanella, Autor ; Vincenzo Matera, Autor . - 2023 . - pp. 451-458.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 5 (Octubre) . - pp. 451-458
Palabras clave: Trastorno bipolar, Distribución normal, Trombocitopenia. Resumen: To evaluate whether valproic acid (VPA) can cause thrombocytopenia and impaired platelet function in young patients with new-onset bipolar disorder.
The authors studied 25 new-onset young bipolar patients. Platelet count, platelet aggregation, platelet release, and bleeding time were evaluated before beginning VPA treatment and at least after 10 months of treatment.Link: ./index.php?lvl=notice_display&id=30998